Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques
Kehmia Titanji, Vijayakumar Velu, Lakshmi Chennareddi, Matam Vijay-Kumar, Andrew T. Gewirtz, Gordon J. Freeman, Rama R. Amara
Kehmia Titanji, Vijayakumar Velu, Lakshmi Chennareddi, Matam Vijay-Kumar, Andrew T. Gewirtz, Gordon J. Freeman, Rama R. Amara
View: Text | PDF
Research Article

Acute depletion of activated memory B cells involves the PD-1 pathway in rapidly progressing SIV-infected macaques

  • Text
  • PDF
Abstract

Rapid progression to AIDS is a significant problem, especially in developing countries, where the majority of HIV-infected individuals reside. As rapid disease progression is also frequently observed in SIV-infected macaques, they represent a valuable tool to investigate the pathogenesis of this condition in humans. Here, we have shown that pathogenic SIV infection in rhesus macaques resulted in a rapid depletion (as early as week 2) of activated memory B (CD21–CD27+; mBAct) cells that was strongly associated with rapid disease progression. This depletion was progressive and sustained in rapid progressors, but less severe and transient in typical progressors. Because of the rapid and sustained depletion of mBAct cells, rapid progressors failed to develop SIV-specific Ab responses, showed a decline in non–SIV-specific Ab titers, and succumbed faster to intestinal bacterial infections. Depletion of mBAct cells was strongly associated with preferential depletion of mBAct cells expressing programmed death-1 (PD-1), and in vitro blockade of PD-1 improved their survival. Furthermore, in vivo PD-1 blockade in SIV-infected macaques enhanced Ab responses to non-SIV as well as SIV Ags. Our results identify depletion of mBAct cells as a very early predictor of rapid disease progression in pathogenic SIV infection and suggest an important role for the PD-1 pathway in depletion of mBAct cells and impaired humoral immune responses in SIV-infected macaques.

Authors

Kehmia Titanji, Vijayakumar Velu, Lakshmi Chennareddi, Matam Vijay-Kumar, Andrew T. Gewirtz, Gordon J. Freeman, Rama R. Amara

×

Figure 3

Depletion of mBAct cells is an early predictor of disease progression.

Options: View larger image (or click on image) Download as PowerPoint
Depletion of mBAct cells is an early predictor of disease progression.
 ...
(A) Plasma SIV viral load in rapid (n = 13) and typical (n = 39) progressors at 2 and 12 weeks post infection. (B) Correlation between percentages of mBAct cells prior to infection and change in mBAct cell percentages from week 0 to week 2. (C) Percentages of mBAct cells and correlations between set-point viral load and mBAct cells at 2 or 12 weeks post SIV infection. (D) Proportions of total CD4+ T cells in colorectal tissue, and correlations between set-point viral load and CD4+ T cells in colorectal tissue at 2 or 12 weeks post SIV infection. (E) Proportion of blood TCM cells and correlations between set-point viral load and blood TCM cells at 2 or 12 weeks after SIV infection. For correlation analyses, filled and open symbols represent rapid and typical progressors, respectively. Boxes represent 25th–75th percentiles with medians, and whiskers represent 5th and 95th percentiles. *P < 0.05; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts